Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sceptor Industries was a biotechnology company focused on the development of high-performance air sampling and bio-detection systems. The company's core technology, including the SpinCon and Omni-Sampler systems, was designed to capture and concentrate airborne biological agents such as bacteria, viruses, and toxins for rapid analysis. These products were primarily utilized in bio-defense, environmental monitoring, and industrial hygiene applications to protect public health and national security. Sceptor Industries was acquired by Meso Scale Diagnostics in 2004, which integrated Sceptor's sampling technologies into its own electrochemiluminescence-based detection platforms. The company's innovations played a significant role in the U.S. government's bio-surveillance initiatives during the early 2000s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SCEPTOR Industries.